The sale comes after shares in COVID-19 vaccine maker Moderna soared fivefold in 2020.
MarketWatch.com - Top Stories, MarketWatch
Mon, 03/01/2021 - 11:19am
The sale comes after shares in COVID-19 vaccine maker Moderna soared fivefold in 2020.